Consistently, we showed that idebenone mitigated the sevoflurane-induced mitochondrial dysfunction, synaptic loss, and cognitive impairment, without altering Tau phosphorylation and IL-6 elevation, in the present studies (Figs. 9 and 10). This evidence concerns the gene MAPT and Cognitive impairment.